Oxford University has struck a new collaboration with Serum Institute of India to develop malaria vaccine R78C. The plan targets multiple stages of the malaria parasite to improve effectiveness, while Serum will produce the vaccine at scale. With malaria burden highest across sub Saharan Africa, the pact could accelerate access to a more potent option.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
